We are live on ! Find out more
SGMO

SANGAMO THERAPEUTICS INC
SGMO

Delisted

SGMO was delisted on the 4th of May, 2026.

Back to rankings

122 hedge funds and large institutions have $34.5M invested in SANGAMO THERAPEUTICS INC in 2025 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 33 increasing their positions, 33 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 33

4% less call options, than puts

Call options by funds: $1.77M | Put options by funds: $1.84M

5% less funds holding

Funds holding: 128 → 122 (-6)

6.12% less ownership

Funds ownership: 29.51% → 23.39% (-6.1%)

18% less first-time investments, than exits

New positions opened: 23 | Existing positions closed: 28

45% less capital invested

Capital invested by funds: $62.9M → $34.5M (-$28.4M)

Holders
122
Holders Change
-6
Holders Change %
-4.69%
% of All Funds
1.64%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
23
Increased
33
Reduced
33
Closed
28
Calls
$1.77M
Puts
$1.84M
Net Calls
-$75K
Net Calls Change
+$1.41M

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$1.61M
2
OM
Opaleye Management
Massachusetts
+$1.12M
3
GCP
GSA Capital Partners
United Kingdom
+$990K
4
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$588K
5
GCM
Graham Capital Management
Connecticut
+$359K

Top Sellers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
-$4.13M
2
WA
Wasatch Advisors
Utah
-$2.5M
3
SSA
Schonfeld Strategic Advisors
New York
-$1.78M
4
Millennium Management
Millennium Management
New York
-$1.66M
5
Morgan Stanley
Morgan Stanley
New York
-$1.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
National Bank of Canada
101
National Bank of Canada
Quebec, Canada
$1.48K -$445 -420 -16%
LSA
102
Leonteq Securities AG
Switzerland
$1.48K +$2.4K +2,262 New
Jones Financial Companies
103
Jones Financial Companies
Missouri
$1.14K +$1.47K +1,388 New
Lazard Asset Management
104
Lazard Asset Management
New York
$1K -$46.4K -43,795 -94%
BLC
105
Brown, Lisle/Cummings
Rhode Island
$1K – – –
BNP Paribas Financial Markets
106
BNP Paribas Financial Markets
France
$945 +$1.06K +1,000 +227%
AF
107
Allworth Financial
California
$815 – – –
AWM
108
Activest Wealth Management
Florida
$656 – – –
APW
109
Atlantic Private Wealth
North Carolina
$656 – – –
T
110
Transce3nd
Texas
$656 – – –
CIBC Private Wealth Group
111
CIBC Private Wealth Group
Georgia
$628 – – –
S
112
Sachetta
Massachusetts
$318 – – –
Zurich Cantonal Bank
113
Zurich Cantonal Bank
Switzerland
$286 – – –
SSB
114
Sandy Spring Bank
Maryland
$263 – – –
AF
115
Advisornet Financial
Minnesota
$135 – – –
AFG
116
Albion Financial Group
Utah
$132 – – –
MCM
117
MAI Capital Management
Ohio
$66 – – –
CA
118
Crewe Advisors
Utah
$66 +$106 +100 New
US Bancorp
119
US Bancorp
Minnesota
$7 -$13 -12 -52%
Barclays
120
Barclays
United Kingdom
$1 -$67K -63,247 -100%
CIAM
121
Caitong International Asset Management
Hong Kong
$1 -$4.99K -4,713 -100%
ACP
122
Acuta Capital Partners
California
– -$755K -740,000 Closed
CSS
123
Cubist Systematic Strategies
Connecticut
– -$466K -456,946 Closed
Rafferty Asset Management
124
Rafferty Asset Management
New York
– -$358K -351,337 Closed
EI
125
EAM Investors
California
– -$256K -250,789 Closed
2 3 4
5
6

SGMO Hedge Fund Activity: Q1 2025 in Review

122 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q1 2025, worth a combined $34.5M — down 45% from $62.9M a quarter earlier.

Sellers outnumbered buyers: 28 funds closed out of SGMO and 23 opened new positions — a net loss of 5 holders — while 33 trimmed existing stakes and 33 added.

The largest buyer was Susquehanna International Group, adding an estimated $1.61M. The largest seller was State Street, cutting an estimated $4.13M.

  • 122 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q1 2025, down from 128 in Q4 2024.
  • Funds reported $34.5M of SANGAMO THERAPEUTICS INC stock for Q1 2025, down 45% quarter-over-quarter.
  • 23 funds opened new SANGAMO THERAPEUTICS INC positions in Q1 2025 and 28 closed out, a net change of -5 holders.
  • The largest SANGAMO THERAPEUTICS INC buyer in Q1 2025 was Susquehanna International Group, an estimated $1.61M added.
  • The largest SANGAMO THERAPEUTICS INC seller in Q1 2025 was State Street, an estimated $4.13M sold.

Based on aggregated 13F filings for Q1 2025.